15810288723
We actively seek innovative pharmaceutical assets with global potential and explore licensing and co-development opportunities.
We provide integrated research, development and manufacturing solutions to support partners from early development to commercial supply.
Combining pharmaceutical research, process development and manufacturing capabilities.
Bridging global innovation with China's pharmaceutical ecosystem.
Building sustainable partnerships that extend beyond individual projects.
Peptide platform
GLP-1 & therapeutic peptides
Oncology platform
High potency & targeted therapies
Drug delivery platform
Lipid-based technologies
Process development
Scalable & robust routes
Analytical development
Method design & validation
CMC support
Regulatory-ready packages
Technology transfer
Seamless site-to-site handoff
GMP manufacturing
Early development to commercial supply
We start with a conversation to understand your asset or development need.
Our teams assess the science, the data and the fit with our platforms.
We shape the right model together — licensing, co-development or alliance.
We move forward as partners, from development through to supply.
CanalLotus works alongside sister platforms across the CanalLotus group, including CanalLotus Biotech's global comparator sourcing and clinical supply network, to give partners a single trusted route from discovery through commercial supply.
We welcome discussions with pharmaceutical and biotechnology companies seeking strategic partners for innovative drug development.
15810288723